Drug Profile
HIV vaccine - HIVACAT/Esteve
Alternative Names: HIVACAT AIDS vaccine programme - Hospital Clinic de Barcelona/IrsiCaixa Foundation/EsteveLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator HIVACAT; irsiCaixa Foundation
- Developer ESTEVE; HIVACAT; irsiCaixa Foundation
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for phase-I development in HIV-infections in Spain
- 28 Feb 2019 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in Spain
- 19 Jan 2016 Phase-I clinical trials in HIV infections (Prevention) in Spain (unspecified route)